On January 15, 2023, Catalyst Biosciences, Inc. terminated Grant Blouse Ph.D. from his position as the Chief Scientific Officer of the company, effective as of January 15, 2023 (the Effective Date). Dr. Blouse has agreed to provide consulting services following the Effective Date to provide advice regarding the potential sale or license of the company's legacy hemophilia programs.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 USD | -0.19% | -0.38% | +103.40% |
- Stock Market
- Equities
- CBIO Stock
- News Catalyst Biosciences
- Catalyst Biosciences, Inc. Terminates Grant Blouse from the Position as the Chief Scientific Officer